Circulating HIV-Specific Interleukin-21+CD4+ T Cells Represent Peripheral Tfh Cells with Antigen-Dependent Helper Functions

Immunity

Volumn 44, Issue 1, 2016, Pages 167-178

  Schultz, Bruce T ^a,b,c   Teigler, Jeffrey E ^a,b   Pissani, Franco ^a,b,f   Oster, Alexander F ^a,b   Kranias, Gregory ^a,b   Alter, Galit ^d   Marovich, Mary ^a,b,g   Eller, Michael A ^a,b   Dittmer, Ulf ^c   Robb, Merlin L ^a,b   Kim, Jerome H ^a,e   Michael, Nelson L ^a   Bolton, Diane ^a,b   Streeck, Hendrik ^a,b,c  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e International Vaccine Institute   (South Korea)

^f Immunomic Therapeutics   (United States)

^g NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 21; NEUTRALIZING ANTIBODY; INTERLEUKIN DERIVATIVE;

ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T FOLLICULAR HELPER CELL; CELL SEPARATION; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION;

CELL SEPARATION; ENZYME-LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKINS; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84958897465     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2015.12.011     Document Type: Article

References (45)

1. Bentebibel S.E., Lopez S., Obermoser G., Schmitt N., Mueller C., Harrod C., Flano E., Mejias A., Albrecht R.A., Blankenship D., et al. Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination. Sci. Transl. Med. 2013, 5:176ra32.
2. Boswell K.L., Paris R., Boritz E., Ambrozak D., Yamamoto T., Darko S., Wloka K., Wheatley A., Narpala S., McDermott A., et al. Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection. PLoS Pathog. 2014, 10:e1003853.
3. Burton D.R., Ahmed R., Barouch D.H., Butera S.T., Crotty S., Godzik A., Kaufmann D.E., McElrath M.J., Nussenzweig M.C., Pulendran B., et al. A blueprint for HIV vaccine discovery. Cell Host Microbe 2012, 12:396-407.
4. Chevalier M.F., Jülg B., Pyo A., Flanders M., Ranasinghe S., Soghoian D.Z., Kwon D.S., Rychert J., Lian J., Muller M.I., et al. HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function. J. Virol. 2011, 85:733-741.
5. Chevalier N., Jarrossay D., Ho E., Avery D.T., Ma C.S., Yu D., Sallusto F., Tangye S.G., Mackay C.R. CXCR5 expressing human central memory CD4 T cells and their relevance for humoral immune responses. J. Immunol. 2011, 186:5556-5568.
6. Chung A.W., Ghebremichael M., Robinson H., Brown E., Choi I., Lane S., Dugast A.S., Schoen M.K., Rolland M., Suscovich T.J., et al. Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines. Sci. Transl. Med. 2014, 6:228ra38.
7. Claman H.N., Chaperon E.A. Immunologic complementation between thymus and marrow cells--a model for the two-cell theory of immunocompetence. Transplant. Rev. 1969, 1:92-113.
8. Cohen K., Altfeld M., Alter G., Stamatatos L. Early preservation of CXCR5+ PD-1+ helper T cells and B cell activation predict the breadth of neutralizing antibody responses in chronic HIV-1 infection. J. Virol. 2014, 88:13310-13321.
9. Doria-Rose N.A., Schramm C.A., Gorman J., Moore P.L., Bhiman J.N., DeKosky B.J., Ernandes M.J., Georgiev I.S., Kim H.J., Pancera M., et al. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature 2014, 509:55-62. NISC Comparative Sequencing Program.
10. Elsaesser H., Sauer K., Brooks D.G. IL-21 is required to control chronic viral infection. Science 2009, 324:1569-1572.
11. Fröhlich A., Kisielow J., Schmitz I., Freigang S., Shamshiev A.T., Weber J., Marsland B.J., Oxenius A., Kopf M. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 2009, 324:1576-1580.
12. Geha R.S., Schneeberger E., Rosen F.S., Merler E. Interaction of human thymus-derived and non-thymus-derived lymphocytes in vitro. Induction of proliferation and antibody synthesis in B lymphocytes by a soluble factor released from antigen-stimulated T lymphocytes. J. Exp. Med. 1973, 138:1230-1247.
13. Hammer S.M., Sobieszczyk M.E., Janes H., Karuna S.T., Mulligan M.J., Grove D., Koblin B.A., Buchbinder S.P., Keefer M.C., Tomaras G.D., et al. Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine. N. Engl. J. Med. 2013, 369:2083-2092. HVTN 505 Study Team.
14. Harker J.A., Lewis G.M., Mack L., Zuniga E.I. Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection. Science 2011, 334:825-829.
15. Haynes B.F., Gilbert P.B., McElrath M.J., Zolla-Pazner S., Tomaras G.D., Alam S.M., Evans D.T., Montefiori D.C., Karnasuta C., Sutthent R., et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 2012, 366:1275-1286.
16. + T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity 2013, 39:770-781.
17. Iwakura Y., Ishigame H., Saijo S., Nakae S. Functional specialization of interleukin-17 family members. Immunity 2011, 34:149-162.
18. Johnson S., Eller M., Teigler J.E., Maloveste S.M., Schultz B.T., Soghoian D.Z., Lu R., Oster A.F., Chenine A.L., Alter G., et al. Cooperativity of HIV-specific cytolytic CD4 T cells and CD8 T cells in control of HIV viremia. J. Virol. 2015, 89:7494-7505.
19. Kim C.H., Rott L.S., Clark-Lewis I., Campbell D.J., Wu L., Butcher E.C. Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells. J. Exp. Med. 2001, 193:1373-1381.
20. Klein F., Mouquet H., Dosenovic P., Scheid J.F., Scharf L., Nussenzweig M.C. Antibodies in HIV-1 vaccine development and therapy. Science 2013, 341:1199-1204.
21. Langenkamp A., Casorati G., Garavaglia C., Dellabona P., Lanzavecchia A., Sallusto F. T cell priming by dendritic cells: thresholds for proliferation, differentiation and death and intraclonal functional diversification. Eur. J. Immunol. 2002, 32:2046-2054.
22. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005, 201:233-240.
23. Locci M., Havenar-Daughton C., Landais E., Wu J., Kroenke M.A., Arlehamn C.L., Su L.F., Cubas R., Davis M.M., Sette A., et al. Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 2013, 39:758-769. International AIDS Vaccine Initiative Protocol C Principal Investigators.
24. Miyara M., Yoshioka Y., Kitoh A., Shima T., Wing K., Niwa A., Parizot C., Taflin C., Heike T., Valeyre D., et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009, 30:899-911.
25. Morita R., Schmitt N., Bentebibel S.E., Ranganathan R., Bourdery L., Zurawski G., Foucat E., Dullaers M., Oh S., Sabzghabaei N., et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 2011, 34:108-121.
26. Moser B., Schaerli P., Loetscher P. CXCR5(+) T cells: follicular homing takes center stage in T-helper-cell responses. Trends Immunol. 2002, 23:250-254.
27. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986, 136:2348-2357.
28. Ozaki K., Spolski R., Feng C.G., Qi C.-F., Cheng J., Sher A., Morse H.C., Liu C., Schwartzberg P.L., Leonard W.J. A critical role for IL-21 in regulating immunoglobulin production. Science 2002, 298:1630-1634.
29. Pallikkuth S., Pahwa S. Interleukin-21 and T follicular helper cells in HIV infection: research focus and future perspectives. Immunol. Res. 2013, 57:279-291.
30. Pissani F., Streeck H. Emerging concepts on T follicular helper cell dynamics in HIV infection. Trends Immunol. 2014, 35:278-286.
31. Ranasinghe S., Flanders M., Cutler S., Soghoian D.Z., Ghebremichael M., Davis I., Lindqvist M., Pereyra F., Walker B.D., Heckerman D., Streeck H. HIV-specific CD4 T cell responses to different viral proteins have discordant associations with viral load and clinical outcome. J. Virol. 2012, 86:277-283.
32. Rasheed M.A., Latner D.R., Aubert R.D., Gourley T., Spolski R., Davis C.W., Langley W.A., Ha S.J., Ye L., Sarkar S., et al. Interleukin-21 is a critical cytokine for the generation of virus-specific long-lived plasma cells. J. Virol. 2013, 87:7737-7746.
33. Recher M., Berglund L.J., Avery D.T., Cowan M.J., Gennery A.R., Smart J., Peake J., Wong M., Pai S.Y., Baxi S., et al. IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivo. Blood 2011, 118:6824-6835.
34. Rerks-Ngarm S., Pitisuttithum P., Nitayaphan S., Kaewkungwal J., Chiu J., Paris R., Premsri N., Namwat C., de Souza M., Adams E., et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 2009, 361:2209-2220. MOPH-TAVEG Investigators.
35. Schaerli P., Willimann K., Lang A.B., Lipp M., Loetscher P., Moser B. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J. Exp. Med. 2000, 192:1553-1562.
36. Schaerli P., Loetscher P., Moser B. Cutting edge: induction of follicular homing precedes effector Th cell development. J. Immunol. 2001, 167:6082-6086.
37. Soghoian D.Z., Streeck H. Cytolytic CD4(+) T cells in viral immunity. Expert Rev. Vaccines 2010, 9:1453-1463.
38. Streeck H., Frahm N., Walker B.D. The role of IFN-gamma Elispot assay in HIV vaccine research. Nat. Protoc. 2009, 4:461-469.
39. + T cell responses in HIV vaccine development. Nat. Med. 2013, 19:143-149.
40. Veldhoen M., Uyttenhove C., van Snick J., Helmby H., Westendorf A., Buer J., Martin B., Wilhelm C., Stockinger B. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 2008, 9:1341-1346.
41. Victora G.D., Nussenzweig M.C. Germinal centers. Annu. Rev. Immunol. 2012, 30:429-457.
42. Victora G.D., Schwickert T.A., Fooksman D.R., Kamphorst A.O., Meyer-Hermann M., Dustin M.L., Nussenzweig M.C. Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell 2010, 143:592-605.
43. Yates N.L., Liao H.X., Fong Y., deCamp A., Vandergrift N.A., Williams W.T., Alam S.M., Ferrari G., Yang Z.Y., Seaton K.E., et al. Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination. Sci. Transl. Med. 2014, 6:228ra39.
44. Yi J.S., Du M., Zajac A.J. A vital role for interleukin-21 in the control of a chronic viral infection. Science 2009, 324:1572-1576.
45. Zhu J., Yamane H., Paul W.E. Differentiation of effector CD4 T cell populations. Annu. Rev. Immunol. 2010, 28:445-489.